期刊文献+

耐万古霉素肠球菌医院感染流行特征与危险因素分析 被引量:18

Prevalence of vancomycin-resistant Enterococci causing nosocomial infections and its risk factors
原文传递
导出
摘要 目的对耐万古霉素肠球菌(VRE)医院感染现状、流行特征及相关危险因素进行分析,为制定VRE医院感染预防控制策略提供科学依据。方法收集医院2010年1月-2014年9月23例VRE医院感染患者的临床及流行病学资料,采用1∶1成组设计病例对照研究,运用单因素及多因素logistic回归分析,探索VRE医院感染发生的危险因素。结果 4年共纳入2 887例住院患者,23例发生VRE医院感染,4年感染率波动较大,为0.20%~1.90%;尿路感染是VRE医院感染最常见的感染类型,占73.91%;科室分布以老年病房最高,占26.09%;8例VRE患者发生混合感染;死亡8例,病死率34.78%;多因素logistic回归分析结果显示,高龄、患有基础疾病、感染前使用过碳青霉烯类抗菌药物是VRE医院感染的独立危险因素。结论老年患者、患有基础疾病、使用碳青霉烯类抗菌药物是VRE医院感染的危险因素,VRE与真菌混合感染提示不良临床结局,临床应严格掌握广谱抗菌药物使用指征,预防VRE的发生和传播。 OBJECTIVE To determine the current status,prevalence and risk factors of vancomycin-resistant Enterococci(VRE)causing nosocomial infections in the hospital so as to provide scientific reference for formulating strategies for prevention and control of nosocomial VRE infections.METHODS Clinical and epidemic data of the patients that were diagnosed with nosocomial VRE infection from Jan.2010 to Sep.2014 were collected,and then a 1∶1case-control study was performed.Single-factor and multi-factor logistic regression analyses were applied to analyze the risk factors.RESULTS Totally 2887 patients during the 4years were enrolled,of which,23 were infected with VRE.The annual incidence of VRE infection fluctuated greatly,ranging from 0.20%to 1.90%.Urinary tract infection was the most common type of nosocomial VRE infections,accounting for 73.91%.The geriatric ward was the predominant affected department,accounting for 26.09%.Co-infections occurred in 8VRE patients,and 8cases died,with the mortality rate of 34.78%.Multiple logistic regression analysis showed that old age,suffering from underlying diseases and usage of carbapenem agents before infections were independent risk factors for acquisition of VRE.CONCLUSIONOld age,suffering from underlying diseases and usage of carbapenem agents are risk factors for nosocomial VRE infections.The co-infections of VRE with fungi may suggest a bad clinical ending.The determined VRE prevalence and risk factors of VRE acquisition are expected to be useful in establishing guidelines for preventing occurrence and spread of VRE infections.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第3期530-532,共3页 Chinese Journal of Nosocomiology
基金 广东省科技计划基金资助项目(2012B031800162)
关键词 耐万古霉素肠球菌 医院感染 流行特征 危险因素 VRE Nosocomial infection Prevalence feature Risk factors
  • 相关文献

参考文献5

  • 1Leclercq R.Epidemiological and resistance issues in multidrug-resistant Staphylococci and Enterococci[J].Clin Microbiol Infect,2009,15(3):224-231.
  • 2Assadian O,Askarian M,Stadler M,et al.Prevalence of vancomycin-resistant Enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz,Iran[J].BMC Infect Dis,2007(7):52.
  • 3Wibbenmeyer L,Williams I,Ward M,et al.Risk factors for acquiring vancomycin-resistant Enterococcus and methicillinresistant Staphylococcus aureus on a burn surgery step-down unit[J].J Burn Care Res,2010,31(2):269-279.
  • 4Mutters NT,Mersch-Sundermann V,Mutters R,et al.Control of the spread of vancomycin-resistant Enterococci in hospitals:epidemiology and clinical relevance[J].Dtsch Arztebl Int,2013,110(43):725-731.
  • 5Zirakzadeh A,Patel R.Vancomycin-resistant Enterococci:colonization,infection,detection,and treatment[J].Mayo Clin Proc,2006,81(4):529-536.

同被引文献174

  • 1沈洪,许淑珍,马纪平.肠球菌转座子介导的耐药基因转移研究进展[J].中华医院感染学杂志,2005,15(7):837-840. 被引量:19
  • 2郑波,王珊,李耘,薛峰,肖永红.万古霉素耐药肠球菌基因及水平转移研究[J].中国临床药理学杂志,2007,23(2):133-136. 被引量:10
  • 3李春艳,杨青.肠球菌耐药性及万古霉素耐药基因研究[J].中国卫生检验杂志,2007,17(12):2244-2246. 被引量:8
  • 4Alburquenque C, Beltran S, Olivares R, et al. Species dis-tribution and susceptibility pattern of Candida spp. : the im-portance to survey also strains isolated from the community[J]. Rev Chilena Infectol, 2013,30 (3) : 244-251.
  • 5Queenan AM, Davies TA,He W, et al. Assessment of thecombination of doripenem plus a fluoroquinolone againstnon-susceptible Acinetobacter baumannii isolates from noso-comial pneumonia patients [J]. J Chemother, 2013,25(3): 141-147.
  • 6Clinical and Laboratory Standards Institute. Performance stand-ards for antimicrobial susceptibility testing, Twentieth informa-tional supplement [S]. CLSI,2010,M100-S20; 16-32.
  • 7Pourhajibagher M, Hashemi FB, Pourakbari B, et al. Anti-microbial Resistance of Acinetobacter baumannii to Imipen-em in Iran: A Systematic Review and Meta-Analysis [J].Open Microbiol J, 2016,10: 32-42.
  • 8Richmond GE, Evans LP, Anderson MJ , et at. The acineto-bacter baumannii two-component system aders regulatesgenes required for multidrug efflux, biofilm formation, and vir-ulence in a strain-specific manner [J]. MBio, 2016,7 (3):e00852.
  • 9Jones RN. Microbial etiologies of hospital-acquired bacterialpneumonia and ventilator-associated bacterial pneumonia[J]. Clin Infect Dis? 2010, 51 Suppl 1: S81-87.
  • 10Liu YM, Chen YS, Toh HS,et al. In vitro susceptibilitiesof non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to2010. results from the study for monitoring antimicrobialresistance trends (SMART) [J]. Int J Antimicrob Agents,2012,40 Suppl; Sll-17.

引证文献18

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部